UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000029960
Receipt number R000034153
Scientific Title Confirmation of the principle of Multi-functional Jones matrix OCT for skin imaging
Date of disclosure of the study information 2017/11/20
Last modified on 2020/11/20 09:37:05

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Confirmation of the principle of Multi-functional Jones matrix OCT for skin imaging

Acronym

Jones matrix OCT evaluation of normal skin

Scientific Title

Confirmation of the principle of Multi-functional Jones matrix OCT for skin imaging

Scientific Title:Acronym

Jones matrix OCT evaluation of normal skin

Region

Japan


Condition

Condition

Normal subjects

Classification by specialty

Dermatology Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To examine the usefulness of information obtained by human skin imaging by Jones matrix OCT in dermatology and cosmetic science.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Qualitative observation of image data obtained by a custom-made imaging device (JM-OCT), and quantitative feature values obtained by the image.

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Diagnosis

Type of intervention

Device,equipment

Interventions/Control_1

Weak near-infra red light illumination to the subject's skin. The light power is confined by the ANSI safety standard.

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1.Normal subjects without marked skin disorder.
2.After receiving sufficient explanation for the participation of this study, those who gained written consent by the with sufficient understanding

Key exclusion criteria

1.Subjects with difficulty in confirming their agreement on participation.
2.Subjects with marked skin disorders.

Target sample size

300


Research contact person

Name of lead principal investigator

1st name Yoshiaki
Middle name
Last name Yasuno

Organization

University of Tsukuba

Division name

Faculty of Medicine

Zip code

305-8577

Address

Tennodai 1-1-1, Tsukuba, Ibaraki,Japan

TEL

0298535217

Email

yasuno@optlab2.bk.tsukuba.ac.jp


Public contact

Name of contact person

1st name Yoshiaki
Middle name
Last name Yasuno

Organization

University of Tsukuba

Division name

Faculty of Medicine

Zip code

305-8577

Address

Tennodai 1-1-1, Tsukuba, Ibaraki,Japan

TEL

0298535217

Homepage URL


Email

yasuno@optlab2.bk.tsukuba.ac.jp


Sponsor or person

Institute

Faculty of Medicine,University of Tsukuba

Institute

Department

Personal name



Funding Source

Organization

Ministry of Education, Culture, Sports, Science and Technology-Japan

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization



Other related organizations

Co-sponsor

Kao

Name of secondary funder(s)

Kao


IRB Contact (For public release)

Organization

Tsukuba Clinical Research & Development Organization

Address

University of Tsukuba Hospital Amakubo 2-1-1, Tsukuba, Ibaraki,Japan

Tel

029-853-3914

Email

rinshokenkyu@un.tsukuba.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2017 Year 11 Month 20 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2017 Year 11 Month 14 Day

Date of IRB


Anticipated trial start date

2017 Year 11 Month 20 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2017 Year 11 Month 14 Day

Last modified on

2020 Year 11 Month 20 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000034153


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name